Option chain shows key data for Sabine Royalty's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Sabine Royalty.

Sabine Royalty (NYSE:SBR) Stock, Option Chain

Sabine Royalty

Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma and Texas.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AIMD

ALLO

ANGO

APLT

ATXI

AXGN

BNZI

CISO

CPRX

CYCC

DRMA

ELAN

EXAI

IMCR

Intelligent Bio Solutions Inc. - Common Stock

INBS

KORE

KRUS

LSDI

NEXI

OMGA

PNST

PTON

PYPD

RCAC

SABS

SMFL

SWVL

TBPH

VERB

VYGR

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Dividends

GLAD

Looking for small cap and micro cap stocks offering solid dividend yields, with future growth potential. These three monthly paying dividend stocks are offering stable passive income for the rest of the year.

Passive Income Ideas For Portfolio Accounts: These 3 High-Yielding Monthly Dividend Payers Offer Potential Growth Opportunities

Earnings

Eurozone

Commodities

Global

ABSI

AEHR

DISCA

MRIN

SYTA

Toward the end of trading Friday, the Dow traded up 0.32% to 36,351.67 while the NASDAQ fell 0.68% to 14,978.67. The S&amp;P also fell, dropping, 0.17% to 4,688.12.



Mid-Afternoon Market Update: Dow Gains Over 100 Points; Aehr Test Systems Shares Slide

Sabine Royalty Trust

Saber - United States Dollar

Sabra Health Care REIT, Inc. - Common Stock

Sabra Health Care REIT Inc

SABRE INS GROUP PLC by SABRE INS GROUP PLC

SPAREBANK 1 SOR NORGE ASA by SPAREBANK 1 SOR NORGE ASA

SpareBank 1 Sor Norge ASA

In the current session, the stock is trading at $62.00, after a 0.56% increase. Over the past month, Sabine Royalty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>) stock increased by 0.19%, and in the past year, by 0.70%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1731677414_0.png" alt="Past Year Chart" />

<h3>Evaluating Sabine Royalty P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 22.62 in the Oil, Gas &amp; Consumable Fuels industry, Sabine Royalty Inc. has a lower P/E ratio of 10.16. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1731677414_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

P/E Ratio Insights for Sabine Royalty

Tuesday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>). 
<h3>What's Happening</h3>
The company announced on Monday that it would pay shareholders a monthly dividend of 41.95 cents per share. On Wednesday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 41.95 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Wednesday. Shareholders who own SBR as of the end of Tuesday's session are eligible to receive the 41.95 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on February 29, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/quote/SBR">Monitor live stock price updates for Sabine Royalty on Benzinga.</a>

Tuesday Is Your Last Chance To Buy Sabine Royalty Before The Dividend Payout

Thursday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a monthly dividend of 43.72 cents per share. On Friday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 43.72 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own SBR as of the end of Thursday's session are eligible to receive the 43.72 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on January 30, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/stock//dividends">Click here</a> to find details on Sabine Royalty's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Sabine Royalty: Dividend Insights

Shares of Applied Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aplt#NASDAQ">APLT</a>) shares fell sharply during Friday&rsquo;s session after the company released topline results of the ARISE-HF Phase 3 trial of AT-001 (caficrestat) in patients with Diabetic Cardiomyopathy (DbCM) at high risk of <a href="https://www.benzinga.com/general/biotech/24/01/36508058/applied-therapeutics-diabetes-associated-heart-disease-drug-fails-in-phase-3-study-stock-plunges">progression to overt heart failure</a>.
The study&#39;s primary endpoint was stabilization or improvement in cardiac functional capacity as measured by Peak VO2 in patients treated with AT-001 1500mg twice daily (BID) compared to placebo.
Applied Therapeutics shares dipped 35.6% to $2.4498 on Friday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Ainos, Inc.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aimd#NASDAQ">AIMD</a>) jumped 112.6% to $3.6805 after falling more than 12% on Thursday.</li>
<li>Revelstone Capital Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcac#NASDAQ">RCAC</a>) shares climbed 89.6% to $10.71. Revelstone Capital Acquisition cancelled special meeting to approve business combination with Set Jet, Inc.</li>
<li>Banzai International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnzi#NASDAQ">BNZI</a>) surged 74% to $2.92. Banzai International signed a non-binding letter of intent to acquire IGLeads, a cutting-edge automated lead generation platform.</li>
<li>Safe and Green Development Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgd#NASDAQ">SGD</a>) shares rose 56.5% to $2.1307. Safe And Green Development recently issued an update on LOI for acquisition of Xene AI Software platform.</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) gained 30% to $7.67</li>
<li>Dermata Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drma#NASDAQ">DRMA</a>) rose climbed 27.8% to $0.78 after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis.</li>
<li>Polished.com Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pol#NYSE">POL</a>) gained 27.2% to $8.05.</li>
<li>Swvl Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/swvl#NASDAQ">SWVL</a>) gained 27.2% to $2.90.</li>
<li>PolyPid Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pypd#NASDAQ">PYPD</a>) gained 25% to $8.44. PolyPid announced $16.2 million private placement of 3,371,312 shares at $4.81 per share.</li>
<li>AxoGen, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axgn#NASDAQ">AXGN</a>) jumped 20.4% to $8.13 as the company reported preliminary unaudited revenue for fourth quarter and full-year 2023. The company also said President and Chief Executive Officer Karen Zaderej plans to retire from the Company by Jan. 2025.</li>
<li>Aurora Mobile Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jg#NASDAQ">JG</a>) jumped 19.2% to $3.79.</li>
<li>Kura Sushi USA, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krus#NASDAQ">KRUS</a>) rose 15.7% to $86.31 following first-quarter results.</li>
<li>The Greenbrier Companies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gbx#NYSE">GBX</a>) gained 13.8% to $50.50 following upbeat earnings.</li>
<li>Peloton Interactive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pton#NASDAQ">PTON</a>) rose 13.1% to $6.93.</li>
<li>Pinstripes Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pnst#NYSE">PNST</a>) shares gained 12.4% to $5.92 after dipping over 35% on Thursday.</li>
<li>Cyclacel Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cycc#NASDAQ">CYCC</a>) rose 12.4% to $2.53.</li>
<li>Elanco Animal Health Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/elan#NYSE">ELAN</a>) gained 8% to $15.72. Stifel analyst Jonathan Block upgraded Elanco Animal Health from Hold to Buy and raised the price target from $13 to $20.</li>
<li>Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) shares rose 7.2% to $0.3212 after falling around 5% on Thursday. Intelligent Bio Solutions recently received National Association of Testing Authorities accreditation for its Intelligent Fingerprinting Drug Screening Solution.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>agilon health, inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/agl#NYSE">AGL</a>) tumbled 35.1% to $7.84 after the company lowered its 2023 financial outlook.</li>
<li>Avenue Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atxi#NASDAQ">ATXI</a>) shares fell 33.7% to $0.2266. Avenue Therapeutics shares jumped over 94% on Thursday after the company announced it reached a final agreement with the FDA for the Phase 3 safety study for IV tramadol.</li>
<li>Medical Properties Trust, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mpw#NYSE">MPW</a>) fell 30.6% to $3.4699 after it disclosed plans to reduce its exposure to tenant Steward Health Care System. Keybanc analyst Austin Wurschmidt downgraded Medical Properties Trust from Overweight to Sector Weight.</li>
<li>AngioDynamics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ango#NASDAQ">ANGO</a>) dipped 22.6% to $6.00 after the company lowered its FY24 guidance.</li>
<li>Lucy Scientific Discovery Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lsdi#NASDAQ">LSDI</a>) fell 22% to $0.1949.</li>
<li>Voyager Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vygr#NASDAQ">VYGR</a>) fell 19.1% to $8.77. Voyager Therapeutics priced its public offering of 7,777,778 common shares at $9 per share.</li>
<li>Verb Technology Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/verb#NASDAQ">VERB</a>) shares fell 17.4% to $0.1340. On Dec. 29, Verb Technology Company entered into a securities purchase agreement with Streeterville Capital where company sold and investor purchased 3,000 shares of the company&#39;s newly designated non-convertible Series C preferred stock for $3 million.</li>
<li>KORE Group Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kore#NYSE">KORE</a>) shares fell 14.8% to $1.04 after jumping over 60% on Thursday.</li>
<li>Allogene Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/allo#NASDAQ">ALLO</a>) shares declined 14.1% to $2.9050. Allogene Therapeutics and Foresight Diagnostics disclosed a partnership to develop MRD-based in-vitro diagnostic for use in ALPHA3, the first pivotal trial for frontline consolidation in large B-cell lymphoma. JMP Securities and Guggenheim downgraded the stock.</li>
<li>Omega Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omga#NASDAQ">OMGA</a>) declined 13.8% to $4.58.</li>
<li>CISO Global Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ciso#NASDAQ">CISO</a>) shares fell 13.7% to $0.0901. CISO Global said the Nasdaq has determined to delist securities from Nasdaq.</li>
<li>Catalyst Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cprx#NASDAQ">CPRX</a>) shares fell 13.4% to $14.81 after announcing pricing of public offering of common stock.</li>
<li>Smart for Life, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smfl#NASDAQ">SMFL</a>) shares fell 12.3% to $1.6408 after jumping around 15% on Thursday.</li>
<li>Exscientia plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/exai#NASDAQ">EXAI</a>) fell 10.8% to $5.84. B of A Securities analyst Michael Ryskin downgraded Exscientia from Buy to Neutral and lowered the price target from $11 to $9.</li>
<li>SAB Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sabs#NASDAQ">SABS</a>) tumbled 9.1% to $5.90.</li>
<li>Sabine Royalty Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sbr#NYSE">SBR</a>) fell 8.7% to $63.02.</li>
<li>Dyne Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dyn#NASDAQ">DYN</a>) shares fell 8% to $17.84. Dyne Therapeutics priced its $300 million public offering of 17.15 million common stock at $17.50 per share.</li>
<li>Immunocore Holdings plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imcr#NASDAQ">IMCR</a>) dipped 7.3% to $64.61. Immunocore announced strategic priorities and pipeline expansion ahead of 42nd Annual J.P. Morgan Healthcare Conference presentation.</li>
<li>Theravance Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tbph#NASDAQ">TBPH</a>) shares fell 6.6% to $10.76 after the company announced results from Phase 4 YUPELRI PIFR-2 study. The company said study did not show a statistically significant difference between yupelri and spiriva handihaler on primary endpoint.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/01/36509097/insiders-buying-synchronoss-technologies-and-2-other-stocks"> Insiders Buying Synchronoss Technologies And 2 Other Stocks</a>

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Wednesday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>). 
<h3>What's Happening</h3>
The company announced on Tuesday that it would pay shareholders a monthly dividend of $1.1431 per share. On Thursday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open $1.1431 lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Thursday. Shareholders who own SBR as of the end of Wednesday's session are eligible to receive the $1.1431 dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on December 29, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To stay up-to-date with the companies that are announcing their dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Sabine Royalty's Ex-Dividend Date Is Thursday, Here's What You Need To Know

Monday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a monthly dividend of 72.08 cents per share. On Tuesday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 72.08 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Tuesday. Shareholders who own SBR as of the end of Monday's session are eligible to receive the 72.08 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on November 29, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/quote/SBR">Monitor live stock price updates for Sabine Royalty on Benzinga.</a>

Sabine Royalty's Ex-Dividend Date Is Tuesday, Here's What You Need To Know

Thursday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a monthly dividend of 27.87 cents per share. On Friday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 27.87 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own SBR as of the end of Thursday's session are eligible to receive the 27.87 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on October 30, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/quote/SBR">Track real-time stock fluctuations for Sabine Royalty on Benzinga.</a>

Thursday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a monthly dividend of 32.05 cents per share. On Friday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 32.05 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own SBR as of the end of Thursday's session are eligible to receive the 32.05 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on July 31, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Monday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a monthly dividend of 46.55 cents per share. On Tuesday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 46.55 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Tuesday. Shareholders who own SBR as of the end of Monday's session are eligible to receive the 46.55 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on March 29, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Monday Is Your Last Chance To Buy Sabine Royalty Before The Dividend Payout

Monday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a monthly dividend of 63.73 cents per share. On Tuesday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 63.73 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Tuesday. Shareholders who own SBR as of the end of Monday's session are eligible to receive the 63.73 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on February 28, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To stay up-to-date with the companies that are announcing their dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Thursday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a monthly dividend of 63.15 cents per share. On Friday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 63.15 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own SBR as of the end of Thursday's session are eligible to receive the 63.15 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on January 31, 2023. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To read more news on Sabine Royalty <a href="https://www.benzinga.com/stock//">click here</a>
<a href="https://www.benzinga.com/calendars/dividends">Click here</a> to visit our Dividends Calendar.

Sabine Royalty's Ex-Dividend Date Is Friday, Here's What You Need To Know

WIIM

ARCH

CHRD

CIVI

ESTE

EURN

MTDR

PDCE

PUMP

SDRL

VIST

Shares of several oil & gas companies are trading lower as oil prices fall amid macroeconomic uncertainty.

Thursday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a monthly dividend of $1.0167 per share. On Friday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open $1.0167 lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Friday. Shareholders who own SBR as of the end of Thursday's session are eligible to receive the $1.0167 dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on October 31, 2022. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To stay up-to-date with the companies that are announcing their dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Thursday Is Your Last Chance To Buy Sabine Royalty Before The Dividend Payout

BOOM

CEIX

DWSN

LTBR

SBOW

VNOM

Shares of several oil-related stocks are trading higher as oil rises amid reports suggesting OPEC+ is considering an oil production cut of 1 million barrels per day.

ARLP

BORR

ROCC

SHEL

SLCA

STNG

TALO

TRGP

WFRD

WTTR

Shares of several energy companies are trading lower amid strength in the dollar and raised fears of an economic slowdown as investors continue to assess Wednesday's Fed commentary and 75 bps rate hike.

Tuesday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>). 
<h3>What's Happening</h3>
The company announced on Friday that it would pay shareholders a monthly dividend of 83.6 cents per share. On Wednesday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 83.6 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Wednesday. Shareholders who own SBR as of the end of Tuesday's session are eligible to receive the 83.6 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on September 29, 2022. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
<a href="https://www.benzinga.com/stock//dividends">Click here</a> to find details on Sabine Royalty's previous dividends.
To keep track of which companies are distributing dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Looking for small cap and micro cap stocks offering solid dividend yields, with future growth potential. These three monthly paying <a href="https://www.benzinga.com/news/large-cap/22/08/28499389/these-5-dividend-payers-just-got-a-lot-more-attractive-seeking-passive-income-in-the-energy-sector">dividend stocks</a> are offering stable passive income for the rest of the year.
High-Yielding Monthly Dividend Stock #1: Ellington Financial Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/efc#NYSE">EFC</a>)
Dividend Yield: 11.49%
Annual Dividend: $1.60
Frequency: Monthly
Sector: Financials
Ellington Financial does not have a consistent track record of raising its dividends as it has raised them once in the last year. Ellington Financial is a micro cap specialty finance company&nbsp;that focuses on investing in residential <a href="https://www.benzinga.com/news/22/07/28066803/housing-beat-mortgage-rates-soar-again-non-qm-rides-on-the-best-and-worst-rental-markets">mortgage</a>-backed securities guaranteed by U.S. government agency or a U.S. government-sponsored entity, alternative A-paper, subprime residential mortgage loans, mortgage servicing rights, mortgage-related derivatives, commercial mortgage-backed securities and other commercial real estate debt.
In the second quarter of 2022, Ellington posted a net income loss of $64.9 million that was marked by extreme volatility, rising interest rates&nbsp;and weakness in both the fixed income and equity markets, said Laurence Penn, its president and CEO.
High-Yielding Monthly Dividend Stock #2: Sabine Royalty Trust (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sbr#NYSE">SBR</a>)
Dividend Yield: 8.89%
Annual Dividend: $6.46
Frequency: Monthly
Sector: Energy
Sabine Royalty Trust does not consistently raise dividends as it has raised dividends once in the last year. Sabine Royalty is an express <a href="https://www.benzinga.com/money/setting-up-a-trust/">trust</a>&nbsp;formed to receive Sabine Corporation&#39;s royalty and mineral interests, including landowner&#39;s royalties, overriding royalty interests, undeveloped oil and gas properties, minerals production payments, and any other similar, non-participatory interest, in certain Royalty Properties.
In the second quarter of 2022, Sabine Royalty increased income to $27 million compared to $12 million in last year&#39;s prior-quarter, up 125% year-over-year.
Go To:&nbsp;<a href="https://www.benzinga.com/real-estate/reit/22/08/28438429/four-reits-that-pay-monthly-dividends">Four REITS That Pay Monthly Dividends</a>
High-Yielding Monthly Dividend Stock #3: Gladstone Capital Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/glad#NYSE">GLAD</a>)
Dividend Yield: 7.53%
Annual Dividend: 81 cents&nbsp;
Frequency: Monthly
Sector: Financials
Gladstone Capital Corporation is another micro cap stock that has raised dividends once in the past year. Gladstone Capital is an externally managed, closed-end, non-diversified management investment company with investment objectives to grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness and make distributions to stockholders that grow over time.
In the third quarter of 2022, Gladstone invested $48.7 million in three new portfolio companies and $18.6 million in existing portfolio companies, while receiving $6.3 million in repayments and net proceeds.

Wednesday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>).
<h3>What&#39;s Happening</h3>
The company announced on Tuesday that it would pay shareholders a monthly dividend of 55 cents per share. On Thursday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 55 cents lower than it would have opened on any other day.
In order to be eligible to receive a company&#39;s dividend, shareholders must own the stock prior to the ex-dividend date&mdash;in this case, Thursday. Shareholders who own SBR as of the end of Wednesday&#39;s session are eligible to receive the 55 cents dividend payout for every share that they own.
According to the company, this dividend will be paid out to shareholders on July 29, 2022. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way.
To read more news on Sabine Royalty <a href="https://www.benzinga.com/stock//">click here</a>
<a href="https://www.benzinga.com/calendars/dividends">Click here</a> to visit our Dividends Calendar.

CLMT

ETRN

GASS

RTLR

USAC

Shares of energy companies are trading lower despite a gain in crude futures. Wednesday's Fed rate hike decision has pressured equities across sectors while recent pressure from US President Biden on oil companies could be further impacting the sector.

Monday marks the last chance for investors to receive the next dividend payout from Sabine Royalty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBR#NYSE">SBR</a>). 
<h3>What's Happening</h3>
The company announced on Wednesday that it would pay shareholders a monthly dividend of 72 cents per share. On Tuesday, Sabine Royalty will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 72 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Tuesday. Shareholders who own SBR as of the end of Monday's session are eligible to receive the 72 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on June 29, 2022. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To read more news on Sabine Royalty <a href="https://www.benzinga.com/stock//">click here</a>
<a href="https://www.benzinga.com/calendars/dividends">Click here</a> to visit our Dividends Calendar.

Comments

Sabine Royalty

Sabine Royalty (SBR) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga